Taken together, our findings provided evidence for the role of NUSAP1 in the progression of astrocytoma and the potential of NUSAP1 as a prognostic biomarker as well as target in astrocytoma treatment. The gene discussed is NUSAP1; the disease is astrocytoma (excluding glioblastoma).